Expertise in
9
conditions

Dr. Ryan S. Jackson

General Surgery
Office
4921 Parkview Pl Ste 11A, 
Saint Louis, MO 
Clinical Trials:Currently Recruiting for 1 Trial
Accepting New Patients
17 Years of Experience
Expertise in
9
conditions
Office
4921 Parkview Pl Ste 11A, 
Saint Louis, MO 

Overview

Ryan Jackson is a General Surgeon practicing medicine in Saint Louis, Missouri. He has been practicing medicine for over 17 years.

Dr. Jackson is highly rated in 9 conditions, according to our data. His clinical expertise encompasses Thyroid Cancer, Follicular Thyroid Cancer, Anaplastic Thyroid Cancer, Laryngectomy, and Gastrostomy.

He is actively involved in clinical research, co-authoring 150 peer reviewed articles and participating in 8 clinical trials. Dr. Jackson is currently accepting new patients.

Graduate Year

2009

Specialties

General Surgery

Licenses

Otolaryngology in MO

Hospital Affiliations

Barnes-Jewish West County Hospital
Barnes Jewish Hospital
Memorial Hospital

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Cox Health
  • EPO
  • PPO
Essence Healthcare
  • INSURANCE PLAN
  • MEDICARE MAPD
Health Alliance
  • EPO
  • HMO
  • POS
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Meridian Choice
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 8 Less Insurance Carriers -

Locations

Office
4921 Parkview Pl Ste 11A, Saint Louis, MO 63110
Other Locations
Washington University
660 S Euclid Ave, Saint Louis, MO 63110

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

8 Clinical Trials

A Phase II Randomized Trial of Adjuvant Therapy With Pembrolizumab After Resection of Recurrent/Second Primary Head and Neck Squamous Cell Carcinoma With High Risk Features
A Phase II Randomized Trial of Adjuvant Therapy With Pembrolizumab After Resection of Recurrent/Second Primary Head and Neck Squamous Cell Carcinoma With High Risk Features
Enrollment Status: Recruiting
Publish Date: August 24, 2026
Intervention Type: Procedure, Drug, Radiation, Biological
Study Drugs: Carboplatin, Cisplatin, Pembrolizumab
Study Phase: Phase 2
Los Tres Paso Trial: Step One - Neoadjuvant Palbociclib Monotherapy, Step Two - Concurrent Chemoradiation Therapy, and Step Three - Adjuvant Palbociclib Monotherapy in Patients With p16INK4a Negative, HPV-Unrelated Head and Neck Squamous Cell Carcinoma
Los Tres Paso Trial: Step One - Neoadjuvant Palbociclib Monotherapy, Step Two - Concurrent Chemoradiation Therapy, and Step Three - Adjuvant Palbociclib Monotherapy in Patients With p16INK4a Negative, HPV-Unrelated Head and Neck Squamous Cell Carcinoma
Enrollment Status: Active_not_recruiting
Publish Date: April 21, 2026
Intervention Type: Drug, Procedure, Radiation
Study Drugs: Palbociclib, Cetuximab, Cisplatin
Study Phase: Phase 2
Phase II Trial of Surgery Followed by Risk-Directed Post-Operative Adjuvant Therapy for HPV-Related Oropharynx Squamous Cell Carcinoma: The Minimalist Trial (MINT)
Phase II Trial of Surgery Followed by Risk-Directed Post-Operative Adjuvant Therapy for HPV-Related Oropharynx Squamous Cell Carcinoma: The Minimalist Trial (MINT)
Enrollment Status: Completed
Publish Date: April 21, 2026
Intervention Type: Other, Drug, Radiation, Procedure
Study Drug: Cisplatin
Study Phase: Phase 2
Induction Paclitaxel Followed by Concurrent Paclitaxel and Radiation Therapy for Cutaneous Angiosarcoma
Induction Paclitaxel Followed by Concurrent Paclitaxel and Radiation Therapy for Cutaneous Angiosarcoma
Enrollment Status: Active_not_recruiting
Publish Date: January 21, 2026
Intervention Type: Drug, Radiation, Procedure
Study Drug: Paclitaxel
Study Phase: Phase 1/Phase 2
Phase II Non-Randomized Three Arm Trial of Induction Chemotherapy With Nab-Paclitaxel and Cisplatin (AP: Arms 1 and 3) or Single Agent Nab-paclitaxel (A: Arm 2) as Induction Therapy Followed by Definitive Concurrent Chemoradiation for Locally Advanced Squamous Cell Carcinoma of the Head and Neck (HNSCC): The APA Trial.
Phase II Non-Randomized Three Arm Trial of Induction Chemotherapy With Nab-Paclitaxel and Cisplatin (AP: Arms 1 and 3) or Single Agent Nab-paclitaxel (A: Arm 2) as Induction Therapy Followed by Definitive Concurrent Chemoradiation for Locally Advanced Squamous Cell Carcinoma of the Head and Neck (HNSCC): The APA Trial.
Enrollment Status: Completed
Publish Date: December 27, 2024
Intervention Type: Drug, Radiation, Biological
Study Drugs: Nab-Paclitaxel, Cisplatin, Cetuximab
Study Phase: Phase 2
Imaging CCR2 Receptors With 64Cu-DOTA-ECL1i in Head and Neck Cancer
Imaging CCR2 Receptors With 64Cu-DOTA-ECL1i in Head and Neck Cancer
Enrollment Status: Terminated
Publish Date: November 19, 2024
Intervention Type: Drug
Study Phase: Phase 1
Evaluation of TraceIT Tissue Marker to Mark the Primary Resection Bed Margins of Oropharyngeal Cancers: a Pilot Study
Evaluation of TraceIT Tissue Marker to Mark the Primary Resection Bed Margins of Oropharyngeal Cancers: a Pilot Study
Enrollment Status: Terminated
Publish Date: July 12, 2022
Intervention Type: Device
Study Phase: Not Applicable
Evaluation of Fluorescence Imaging in Head and Neck Cancer
Evaluation of Fluorescence Imaging in Head and Neck Cancer
Enrollment Status: Terminated
Publish Date: January 18, 2020
Intervention Type: Device
Study Phase: Not Applicable
View 7 Less Clinical Trials

150 Total Publications

Mechanisms Underlying an Enhanced Navigation-Based Intervention to Improve Timely Adjuvant Therapy: A Secondary Analysis of the NDURE Randomized Clinical Trial.
Mechanisms Underlying an Enhanced Navigation-Based Intervention to Improve Timely Adjuvant Therapy: A Secondary Analysis of the NDURE Randomized Clinical Trial.
Journal: JAMA otolaryngology-- head & neck surgery
Published: July 23, 2026
Similar Doctors
Expertise in
36
conditions
Dr. Ryan C. Fields
General Surgery
Expertise in
36
conditions
Dr. Ryan C. Fields
General Surgery
Referral may be required
Before you request

Washington University

660 S Euclid Ave, 
Saint Louis, MO 
 (0.1 miles away)
314-286-1694
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Ryan Fields is a General Surgeon practicing medicine in Saint Louis, Missouri. Dr. Fields is highly rated in 36 conditions, according to our data. His clinical expertise encompasses Neuroendocrine Tumor, Pancreatic Cancer, Gallbladder Cancer, Pancreaticoduodenectomy, and Pancreatectomy. Dr. Fields is currently accepting new patients.

Expertise in
20
conditions
Dr. Steven M. Strasberg
General Surgery
Expertise in
20
conditions
Dr. Steven M. Strasberg
General Surgery
Referral may be required

Washington University

660 S Euclid Ave, 
Saint Louis, MO 
 (0.1 miles away)
314-362-7147
Languages Spoken:
English

Steven Strasberg is a General Surgeon practicing medicine in Saint Louis, Missouri. Dr. Strasberg is highly rated in 20 conditions, according to our data. His clinical expertise encompasses Gallbladder Disease, Cholecystitis, Pancreatic Cancer, Gallbladder Removal, and Hepato-Pancreato-Biliary Surgery.

Expertise in
14
conditions
Expertise in
14
conditions
Referral may be required

Barnes Jewish West County Hospital

12634 Olive Blvd, 
Saint Louis, MO 
 (11.3 miles away)
314-996-8000
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Julie Margenthaler is a General Surgeon practicing medicine in Saint Louis, Missouri. Dr. Margenthaler is highly rated in 14 conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Paget Disease of the Breast, Intraductal Papilloma, Mastectomy, and Lymphadenectomy. Dr. Margenthaler is currently accepting new patients.

Frequently Asked Questions about Dr. Ryan S. Jackson

How do I make an appointment with Dr. Ryan S. Jackson?

You can book an appointment with Dr. Ryan S. Jackson by calling their office at 314-362-7509. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Ryan S. Jackson a top-rated expert for Thyroid Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Ryan S. Jackson is classified as an Distinguished expert for Thyroid Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Ryan S. Jackson specialize in?

While Dr. Ryan S. Jackson is a General Surgery, they have specific expertise in Thyroid Cancer, Follicular Thyroid Cancer, and Anaplastic Thyroid Cancer. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within General Surgery.

Does Dr. Ryan S. Jackson participate in research or clinical trials?

Yes. Dr. Ryan S. Jackson has published 150 articles and abstracts on conditions like Thyroid Cancer. You can view a list of Dr. Ryan S. Jackson's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Ryan S. Jackson accept my insurance?

Dr. Ryan S. Jackson accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 314-362-7509 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Jackson's expertise for a condition
ConditionClose
    View All 33 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile